Artisan Bio
Dr. Frohlich is a medical oncologist with deep drug development and translational research experience. From 2014-2017, Dr. Frohlich served as the Executive Vice President of Portfolio Strategy for Juno. Prior to that, he held various executive roles, including EVP R&D and Chief Medical Officer at Dendreon Corporation from 2005-2014 and VP and Medical Director for Xcyte Therapies from 2001-2005. Dr. Frohlich brings extensive expertise in immuno-oncology and cell therapy, experience with drug approvals in US and EU, and knowledge of reimbursement and commercialization challenges.
This person is not in the org chart
This person is not in any offices
Artisan Bio
The Artisan team is passionate about crafting customized cell engineering solutions to solve the most challenging problems in human health applications.